Receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 13: Line 13:
'''The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study<ref>DOI 10.1080/07391102.2012.680029</ref>'''
'''The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study<ref>DOI 10.1080/07391102.2012.680029</ref>'''
-
The serotonin type-3 receptor (5-HT3-R) is a cation selective transmembrane protein channel that belongs to the Cys–loop Ligand-Gated Ion Channel (LGIC) superfamily (http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php), which also includes receptors for nicotinic acetylcholine, &#947;-aminobutyric acid and glycine. 5-HT3-R is involved in signal transmission in the central and peripheral nervous system and its malfunctioning leads to neurodegenerative and psychiatric diseases, therefore it is an important target for drug design research. A few drugs active against 5-HT3-R are already on the market, such as, for example, palonosetron (http://en.wikipedia.org/wiki/Palonosetron) and granisetron (http://en.wikipedia.org/wiki/Granisetron).
+
The serotonin type-3 receptor (5-HT3-R) is a cation selective transmembrane protein channel that belongs to the Cys–loop Ligand-Gated Ion Channel (LGIC) superfamily (http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php), which also includes receptors for nicotinic acetylcholine (<scene name='Journal:JBSD:16/Cv/2'>nAChR</scene>, PDB code [[2bg9]]), &#947;-aminobutyric acid and glycine. 5-HT3-R is involved in signal transmission in the central and peripheral nervous system and its malfunctioning leads to neurodegenerative and psychiatric diseases, therefore it is an important target for drug design research. A few drugs active against 5-HT3-R are already on the market, such as, for example, palonosetron (http://en.wikipedia.org/wiki/Palonosetron) and granisetron (http://en.wikipedia.org/wiki/Granisetron).
The 5-HT3R is made of five monomers assembled in a <scene name='Journal:JBSD:16/Cv/4'>pseudo-symmetric pentameric shape</scene> to form an ion channel permeable to small ions (Na+, K+); each subunit contains three domains: an <scene name='Journal:JBSD:16/Cv/3'>intracellular portion, a transmembrane domain and an extracellular region</scene> (shown on the example of nAChR, [[2bg9]]). To date, five different 5-HT3-R subunits have been identified, the 5-HT3 A, B, C, D and E; however, only subunits A and B have been extensively characterised experimentally. The <scene name='Journal:JBSD:16/Cv/6'>ligand binding site</scene> of nAChR is located at the extracellular region, at the interface between two monomers (α-γ and α-δ; 2 identical α monomers, chains A and D, are colored in same color - lavender), called the principal and the complementary subunits.
The 5-HT3R is made of five monomers assembled in a <scene name='Journal:JBSD:16/Cv/4'>pseudo-symmetric pentameric shape</scene> to form an ion channel permeable to small ions (Na+, K+); each subunit contains three domains: an <scene name='Journal:JBSD:16/Cv/3'>intracellular portion, a transmembrane domain and an extracellular region</scene> (shown on the example of nAChR, [[2bg9]]). To date, five different 5-HT3-R subunits have been identified, the 5-HT3 A, B, C, D and E; however, only subunits A and B have been extensively characterised experimentally. The <scene name='Journal:JBSD:16/Cv/6'>ligand binding site</scene> of nAChR is located at the extracellular region, at the interface between two monomers (α-γ and α-δ; 2 identical α monomers, chains A and D, are colored in same color - lavender), called the principal and the complementary subunits.
The 3D structure of 5-HT3-R has not been experimentally solved yet; however, it has been obtained computationally by means of homology modelling techniques. (http://salilab.org/modeller/)
The 3D structure of 5-HT3-R has not been experimentally solved yet; however, it has been obtained computationally by means of homology modelling techniques. (http://salilab.org/modeller/)

Revision as of 13:43, 13 April 2021

Nicotinic Acetylcholine Receptor, PDB code 2bg9

Drag the structure with the mouse to rotate

References

  1. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  2. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  3. Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors. Eur J Med Chem. 2010 Nov;45(11):4746-60. Epub 2010 Jul 27. PMID:20724042 doi:10.1016/j.ejmech.2010.07.039
  4. Moreira IS, Fernandes PA, Ramos MJ. Computational alanine scanning mutagenesis--an improved methodological approach. J Comput Chem. 2007 Feb;28(3):644-54. PMID:17195156 doi:10.1002/jcc.20566
  5. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  6. De Rienzo F, Del Cadia M, Menziani MC. A first step towards the understanding of the 5-HT(3) receptor subunit heterogeneity from a computational point of view. Phys Chem Chem Phys. 2012 Sep 28;14(36):12625-36. Epub 2012 Aug 9. PMID:22880201 doi:10.1039/c2cp41028a
  7. Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
  8. Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky

Personal tools